Evaluation of the Effect of Human Recombinant Growth Hormone in Patients With Advanced Heart Failure

NCT00182169 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

80

Enrollment

OTHER

Sponsor class

Conditions

Heart Failure

Interventions

DRUG: Human recombinant growth hormone

Sponsor

Hamilton Health Sciences Corporation